TESSA THERAPEUTICS PTE LTD has a total of 28 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2016. It filed its patents most often in Taiwan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are JANSSEN VACCINES AND PREVENTION B V, JANSSEN VACCINES & PREVENTION BV and PAEAN BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Singapore | 3 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Connolly John Edward | 9 |
#2 | Wang Peter | 8 |
#3 | Vu Dang L | 8 |
#4 | Wu Chunxiao | 8 |
#5 | Petersen Sven Hans | 6 |
#6 | Ong Yijie Philbert | 6 |
#7 | Hopkins Richard | 6 |
#8 | Connolly John | 5 |
#9 | Toh Han Chong | 4 |
#10 | Chiang Cheryl Lai-Lai | 4 |
Publication | Filing date | Title |
---|---|---|
TW201923073A | Modified K562 cell | |
WO2018138003A1 | TGF-ß DECOY RECEPTOR | |
EP3516043A1 | T cell expansion method | |
CA3031846A1 | Chimeric antigen receptor | |
US2017028042A1 | T cell expansion |